2025 third_quarter Filing
Q3Income
$60K
Filed
October 16, 2025
Lobbying Activities
Health IssuesView all
Issues related to cell and gene therapy and radioligand therapies Pharmaceutical pricing Issues related to the development of therapies for rare diseases 340B Drug Discount Program Supply chain issues affecting pharmaceutical products Implementation of the Inflation reduction Act Pharmaceutical innovation PBM policy issues HR 1672 The Maintaining Investments in New Innovations (MINI) Act Intellectual property Issues Tariff issues affecting the pharmaceutical industry EPIC Act Most Favored Nation (MFN) policy
Contacted:Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE
Lobbyists (10)
ZACHARY PFISTER
EMILY FELDER
ADAM STEINMETZ
DAVID REID